feed icon

A substantial majority, but a message nonetheless

Posted on May 31, 2009 at 10:10 pm

The quest by dissident shareholder Bristol Capital to snag two seats on Advocat’s board fell short Friday, garnering a not insignificant 25.6 percent of the votes cast. A year ago, Bristol’s call for the board to pursue a sale received 14 percent of shareholders’ votes. Since then, the shares (Ticker: AVCA) have lost 70 percent of their value.

Another sign Advocat is taking Bristol’s board challenge seriously

Posted on May 29, 2009 at 6:51 am

Chad McCurdy, the nursing home operator’s largest shareholder – and since last spring, a board member – says he has picked up a few more shares lately and goes to great lengths to say he supports the company-nominated director candidates over the challengers from Bristol Capital.

Being a large shareholder or having investment banking relationships does not by itself add additional value to our board. I have numerous relationships with investment bankers at very large and well respected firms as do other members of your board. We listen to what our current bankers tell and draw upon other relationships for further advice and counsel.

Advocat responds with proxy advisors’ nod

Posted on May 27, 2009 at 11:57 am

The day after disgruntled investor Bristol Capital said a proxy advisory firm told shareholders to abstain from voting for Advocat’s board members, the company says RiskMetrics also is recommending that investors not vote for Bristol’s nominees. Another advisory firm Glass Lewis is calling for the same.

“Given that the Dissident lacks a strategic plan, that its nominees do not have public company board experience and have less health care industry experience than the incumbent nominees as well as the board’s responsiveness to shareholder concerns, we will refrain from withholding support from the incumbent nominees. Accordingly, we recommend that shareholders vote for both nominees.”

Proxy advisors almost agree with Advocat investor

Posted on May 26, 2009 at 8:18 am

RiskMetrics Group says investors should withhold their votes for the two directors up for re-election at the nursing home chain. A California investment firm that owns more than 7 percent of the company (Ticker: AVCA) is pushing for big changes.

Advocat investors push for board seats ahead of vote

Posted on May 19, 2009 at 8:24 am

L.A.-based Bristol Capital, which has been critical of Advocat’s board for years over performance and compensation, makes its official overture to investors ahead of the company’s May 29 annual meeting. The short version: Bristol, which owns more than 7 percent of Advocat (Ticker: AVCA) says the company has “grossly indulgent compensation practices, ineffective management oversight and a Board that has become disconnected from stockholders and market realities.”

For the record, no

Posted on May 5, 2009 at 12:13 pm

In its proxy statement, the board of nursing home operator Advocat says shareholders should not vote for the director candidates nominated by California investment firm Bristol Capital.

Recent Comments

The Conglomerate